Suitability of conventional systematic vs. MRI-guided targeted biopsy approaches to assess surgical treatment delay for radical prostatectomy.
Mykyta KachanovLars BudäusJorn H WittChristian WagnerJoerg ZinkeBernhard FangmeyerAndreas SchütteTilmann SpiekerDirk BeyersdorffMarkus GraefenPawel RachubinskiSami-Ramzi Leyh-BannurahPublished in: World journal of urology (2022)
Treatment delay remained independently associated with radical prostatectomy GGG upgrade after adjustment for clinical variables in the patients diagnosed with SBx alone, but not in those who received combined TBx + SBx. These findings can be explained through inherent misclassification rates of SBx, potentially obfuscating historical observations of natural PCa progression and potential dangers of treatment delay. Thus, mpMRI-guided combined TBx + SBx appears mandatory for prospective delay-based examinations of PCa.
Keyphrases
- radical prostatectomy
- prostate cancer
- end stage renal disease
- magnetic resonance imaging
- ejection fraction
- newly diagnosed
- chronic kidney disease
- computed tomography
- combination therapy
- patient reported outcomes
- cancer therapy
- peritoneal dialysis
- contrast enhanced
- climate change
- ultrasound guided
- patient reported
- fine needle aspiration